ACL Tear
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
ArthrexCA - Santa Barbara
1 programACL reconstruction with bone marrow, demineralized bone marix, and internal brace augmentationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Colorado TherapeuticsBFR Cuff
ArthrexACL reconstruction with bone marrow, demineralized bone marix, and internal brace augmentation
Clinical Trials (2)
Total enrollment: 138 patients across 2 trials
Comparison of Methods in Post Operative Knee Arthroscopy Rehabilitation
Start: Nov 2022Est. completion: Nov 202578 patients
N/ARecruiting
NCT04178538ArthrexACL reconstruction with bone marrow, demineralized bone marix, and internal brace augmentation
The Effect of Fertilized ACL Technique on Outcomes of ACL Reconstruction in Young Adults
Start: Dec 2019Est. completion: Nov 202360 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 138 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.